Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Testing effectiveness (Phase 2)Study completedNCT00699881
What this trial is testing

Study of Cetuximab to Treat Gastric Cancer

Who this might be right for
Gastric Cancer
Fudan University 61
Testing effectiveness (Phase 2)Looking for participantsNCT06031584
What this trial is testing

BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors

Who this might be right for
Her2-positive/Low-expression Urinary and Digestive Tract Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)UnknownNCT04118933
What this trial is testing

PD-1 Antibody JS001 in MSI-H Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Xu jianmin 40
Testing effectiveness (Phase 2)Study completedNCT04491955
What this trial is testing

Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers

Who this might be right for
Small Bowel CancersColorectal Cancers
National Cancer Institute (NCI) 32
Not applicableUnknownNCT06205732
What this trial is testing

A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.

Who this might be right for
Carcinoma, Hepatocellular
Qianfoshan Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00868114
What this trial is testing

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Leo W. Jenkins Cancer Center 24
Early research (Phase 1)Looking for participantsNCT06764316
What this trial is testing

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Bayer 148
Not applicableStudy completedNCT05487248
What this trial is testing

On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients

Who this might be right for
Unresectable Locally Advanced Colorectal CancerMetastatic Colorectal CancerCandidate for Third-line or Subsequent Lines of Therapy
Jules Bordet Institute 103
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)UnknownNCT00149578
What this trial is testing

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Health Research Institutes, Taiwan 45
Testing effectiveness (Phase 2)UnknownNCT02942563
What this trial is testing

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
RenJi Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01874938
What this trial is testing

LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Eli Lilly and Company 15
Large-scale testing (Phase 3)Study completedNCT00905047
What this trial is testing

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Oscar Lambret 89
Testing effectiveness (Phase 2)Looking for participantsNCT07463248
What this trial is testing

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wang Xin 64
Testing effectiveness (Phase 2)Study completedNCT00035087
What this trial is testing

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic Neoplasms
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT00072332
What this trial is testing

Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT01906216
What this trial is testing

Sorafenib Chemoembolization Evaluation Controlled Trial

Who this might be right for
Hepatocellular Carcinoma
Air Force Military Medical University, China 199
Testing effectiveness (Phase 2)UnknownNCT05424432
What this trial is testing

Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus

Who this might be right for
Locally Advanced Esophageal Carcinoma
Jiangsu Cancer Institute & Hospital 63
Large-scale testing (Phase 3)Study completedNCT01015833
What this trial is testing

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7+7 more
National Cancer Institute (NCI) 356
Next Page